Alkermes’ Constipation Drug Target Boosted by Study Results

Alkermes Inc. has returned positive Phase 2 study results for its drug candidate, ALKS 37, developed to treat constipation brought on by opioid use. The company is now eyeing development of the drug candidate in mid-2011.
Mass High Tech